Robert J. Glynn

86.0k total citations · 19 hit papers
577 papers, 61.1k citations indexed

About

Robert J. Glynn is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Statistics and Probability. According to data from OpenAlex, Robert J. Glynn has authored 577 papers receiving a total of 61.1k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Economics and Econometrics, 139 papers in Cardiology and Cardiovascular Medicine and 103 papers in Statistics and Probability. Recurrent topics in Robert J. Glynn's work include Health Systems, Economic Evaluations, Quality of Life (134 papers), Advanced Causal Inference Techniques (74 papers) and Lipoproteins and Cardiovascular Health (62 papers). Robert J. Glynn is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (134 papers), Advanced Causal Inference Techniques (74 papers) and Lipoproteins and Cardiovascular Health (62 papers). Robert J. Glynn collaborates with scholars based in United States, Canada and Germany. Robert J. Glynn's co-authors include Paul M. Ridker, Sebastian Schneeweiß, Jerry Avorn, Jean MacFadyen, Peter Libby, Jack M. Guralnik, Til Stürmer‎, Robert B. Wallace, Paul A. Scherr and Dan G. Blazer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Robert J. Glynn

569 papers receiving 59.0k citations

Hit Papers

A Short Physical Performance Battery Assessing Lower Extr... 1987 2026 2000 2013 1994 2008 2009 2006 2009 2.0k 4.0k 6.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission
    1994 7.4k citations Robert J. Glynn, Paul A. Scherr et al. profile →
  2. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
    2008 4.7k citations Paul M. Ridker, Eleanor Danielson et al. New England Journal of Medicine profile →
  3. Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
    2009 2.9k citations Paul M. Ridker, Eleanor Danielson et al. profile →
  4. Variable Selection for Propensity Score Models
    2006 1.6k citations M. Alan Brookhart, Sebastian Schneeweiß et al. American Journal of Epidemiology profile →
  5. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
    2009 845 citations Sebastian Schneeweiß, Jeremy A. Rassen et al. profile →
  6. C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction
    1998 805 citations Paul M. Ridker, Robert J. Glynn et al. Circulation profile →
  7. A combined comorbidity score predicted mortality in elderly patients better than existing scores
    2011 768 citations Joshua J. Gagne, Robert J. Glynn et al. profile →
  8. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
    2009 751 citations Paul M. Ridker, Eleanor Danielson et al. profile →
  9. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
    1987 617 citations Robert J. Glynn et al. profile →
  10. Results of Multivariable Logistic Regression, Propensity Matching, Propensity Adjustment, and Propensity-based Weighting under Conditions of Nonuniform Effect
    2005 574 citations Robert J. Glynn et al. American Journal of Epidemiology profile →
  11. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
    2012 562 citations Paul M. Ridker, Jean MacFadyen et al. profile →
  12. A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
    2009 543 citations Robert J. Glynn, Eleanor Danielson et al. New England Journal of Medicine profile →
  13. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods
    2005 524 citations Til Stürmer‎, Robert J. Glynn et al. profile →
  14. Full Coverage for Preventive Medications after Myocardial Infarction
    2011 508 citations Jerry Avorn, Robert J. Glynn et al. New England Journal of Medicine profile →
  15. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
    2019 458 citations Brendan M. Everett, Jan H. Cornel et al. Circulation profile →
  16. Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index
    2017 426 citations Sebastian Schneeweiß, Robert J. Glynn et al. profile →
  17. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
    2018 395 citations Paul M. Ridker, Peter Libby et al. profile →
  18. One‐to‐many propensity score matching in cohort studies
    2012 392 citations Jeremy A. Rassen, Jessica A. Myers et al. Pharmacoepidemiology and Drug Safety profile →
  19. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
    2023 325 citations Paul M. Ridker, Deepak L. Bhatt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Glynn United States 115 14.5k 13.2k 9.0k 8.4k 7.7k 577 61.1k
Peter C. Austin Canada 116 14.4k 1.0× 20.9k 1.6× 11.4k 1.3× 9.7k 1.1× 4.4k 0.6× 908 75.0k
Paul Glasziou Australia 110 10.5k 0.7× 7.2k 0.5× 8.2k 0.9× 7.2k 0.9× 4.4k 0.6× 647 68.0k
Ewout W. Steyerberg Netherlands 133 23.6k 1.6× 12.7k 1.0× 16.6k 1.8× 5.9k 0.7× 3.1k 0.4× 1.1k 84.3k
Andrew D Oxman Norway 93 18.6k 1.3× 9.1k 0.7× 12.3k 1.4× 11.1k 1.3× 4.9k 0.6× 300 107.1k
Víctor M. Montori United States 123 13.3k 0.9× 7.2k 0.5× 9.5k 1.1× 7.1k 0.8× 19.6k 2.5× 695 77.1k
Rory Collins United Kingdom 86 15.0k 1.0× 23.5k 1.8× 7.1k 0.8× 4.5k 0.5× 9.8k 1.3× 245 62.1k
Holger J. Schünemann Canada 118 15.6k 1.1× 8.7k 0.7× 11.2k 1.2× 9.0k 1.1× 3.9k 0.5× 712 87.8k
Harlan M. Krumholz United States 160 14.5k 1.0× 50.3k 3.8× 9.8k 1.1× 13.6k 1.6× 6.6k 0.9× 1.3k 96.5k
Doug Altman United Kingdom 43 12.8k 0.9× 6.4k 0.5× 7.3k 0.8× 3.9k 0.5× 3.3k 0.4× 93 64.7k
Stuart Pocock United Kingdom 117 32.9k 2.3× 37.0k 2.8× 16.9k 1.9× 8.7k 1.0× 16.1k 2.1× 582 143.9k

Countries citing papers authored by Robert J. Glynn

Since Specialization
Citations

This map shows the geographic impact of Robert J. Glynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Glynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Glynn more than expected).

Fields of papers citing papers by Robert J. Glynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Glynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Glynn. The network helps show where Robert J. Glynn may publish in the future.

Co-authorship network of co-authors of Robert J. Glynn

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Glynn. A scholar is included among the top collaborators of Robert J. Glynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Glynn. Robert J. Glynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sesso, Howard D., Susanne Rautiainen, Eunjung Kim, et al.. (2024). Intake of Blueberries, Anthocyanins, and Risk of Eye Disease in Women. Journal of Nutrition. 154(4). 1404–1413. 6 indexed citations
2.
Weberpals, Janick, Sudha R. Raman, Pamela A. Shaw, et al.. (2024). smdi: an R package to perform structural missing data investigations on partially observed confounders in real-world evidence studies. JAMIA Open. 7(1). ooae008–ooae008. 6 indexed citations
3.
Lee, Hemin, Nileesa Gautam, Seanna Vine, et al.. (2022). Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. Clinical and Experimental Rheumatology. 41(1). 110–117. 4 indexed citations
4.
5.
Desai, Rishi, Robert J. Glynn, Brendan M. Everett, et al.. (2022). Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care. American Heart Journal. 254. 203–215. 12 indexed citations
6.
Bohn, Justin, Sebastian Schneeweiß, Robert J. Glynn, et al.. (2019). Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches. SHILAP Revista de lepidopterología. 7(1). 27–27. 3 indexed citations
7.
Everett, Brendan M., Jan H. Cornel, Mitja Lainščak, et al.. (2019). Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 139(10). 1289–1299. 458 indexed citations breakdown →
8.
Ridker, Paul M., Eva Lonn, Nina P. Paynter, Robert J. Glynn, & Salim Yusuf. (2017). Primary Prevention With Statin Therapy in the Elderly. Circulation. 135(20). 1979–1981. 89 indexed citations
9.
Franklin, Jessica M., Wesley Eddings, Robert J. Glynn, & Sebastian Schneeweiß. (2015). Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses. American Journal of Epidemiology. 182(7). 651–659. 51 indexed citations
10.
Wyss, Richard, Mark Lunt, M. Alan Brookhart, Robert J. Glynn, & Til Stürmer‎. (2014). Reducing Bias Amplification in the Presence of Unmeasured Confounding through Out-of-Sample Estimation Strategies for the Disease Risk Score. SHILAP Revista de lepidopterología. 2(2). 131–146. 18 indexed citations
11.
Rassen, Jeremy A., Robert J. Glynn, Kenneth J. Rothman, Soko Setoguchi, & Sebastian Schneeweiß. (2011). Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiology and Drug Safety. 21(7). 697–709. 65 indexed citations
12.
Myers, Jessica A., Jeremy A. Rassen, Joshua J. Gagne, et al.. (2011). Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates. American Journal of Epidemiology. 174(11). 1213–1222. 200 indexed citations
13.
Patrick, Amanda R., Sebastian Schneeweiß, M. Alan Brookhart, et al.. (2011). The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiology and Drug Safety. 20(6). 551–559. 102 indexed citations
14.
Ridker, Paul M., Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, et al.. (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine. 359(21). 2195–2207. 4712 indexed citations breakdown →
15.
Ridker, Paul M., Eleanor Danielson, Nader Rifai, & Robert J. Glynn. (2006). Valsartan, Blood Pressure Reduction, and C-Reactive Protein. Hypertension. 48(1). 73–79. 119 indexed citations
16.
Miljanović, Biljana, Robert J. Glynn, David M. Nathan, JoAnn E. Manson, & Debra A. Schaumberg. (2003). Serum Lipid Levels and Diabetic Retinopathy in Type 1 Diabetes Mellitus. Investigative Ophthalmology & Visual Science. 44(13). 3099–3099.
17.
Morris, Martha Clare, Paul A. Scherr, Liesi E. Hebert, et al.. (2002). Association between Blood Pressure and Cognitive Function in a Biracial Community Population of Older Persons. Neuroepidemiology. 21(3). 123–130. 79 indexed citations
18.
White, Michel, Jean L. Rouleau, Christian Hall, et al.. (2001). Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction. American Heart Journal. 142(6). 1056–1064. 35 indexed citations
19.
Glynn, Robert J., et al.. (1998). Concerns About Run-in Periods in Randomized Trials. JAMA. 279(19). 1526–1526. 9 indexed citations
20.
Glynn, Robert J., et al.. (1993). Modification of Increasing Systolic Blood Pressure in the Elderly during the 1980s. American Journal of Epidemiology. 138(6). 365–379. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter C. Austin Breakdown of academic impact, for papers by Paul Glasziou Breakdown of academic impact, for papers by Ewout W. Steyerberg Breakdown of academic impact, for papers by Andrew D Oxman Breakdown of academic impact, for papers by Víctor M. Montori Breakdown of academic impact, for papers by Rory Collins Breakdown of academic impact, for papers by Holger J. Schünemann Breakdown of academic impact, for papers by Harlan M. Krumholz Breakdown of academic impact, for papers by Doug Altman Breakdown of academic impact, for papers by Stuart Pocock
Rankless by CCL
2026